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Catalytically active inclusion bodies (CatIBs) produced in Escherichia coli are an interesting but 
currently underexplored strategy for enzyme immobilization. They can be purified easily and used 
directly as stable and reusable heterogenous catalysts. However, very few examples of CatIBs that 
are naturally formed during heterologous expression have been reported so far. Previous studies 
have revealed that the adenosine 5′‑monophosphate phosphorylase of Thermococcus kodakarensis 
(TkAMPpase) forms large soluble multimers with high thermal stability. Herein, we show that 
heat treatment of soluble protein from crude extract induces aggregation of active protein which 
phosphorolyse all natural 5′‑mononucleotides. Additionally, inclusion bodies formed during the 
expression in E. coli were found to be similarly active with 2–6 folds higher specific activity compared 
to these heat‑induced aggregates. Interestingly, differences in the substrate preference were 
observed. These results show that the recombinant thermostable TkAMPpase is one of rare examples 
of naturally formed CatIBs.
Abbreviations
AMP  Adenosine 5′-monophosphate
TkAMPpase  Thermococcus kodakarensis Adenosine 5′-monophosphate phosphorylase
CatIB  Catalytically active inclusion body
CMP  Cytidine 5′-monophosphate
GMP  Guanosine 5′-monophosphate
HIA  Heat-induced aggregate
IB  Inclusion body
NMP  Nucleoside 5′-monophosphate
dNMP  2′-Deoxy-nucleoside 5′-monophosphate
R15P  Ribose-1,5-bisphosphate
UMP  Uridine 5′-monophosphate
Heterologous expression of genes in Escherichia coli often leads to intracellular aggregation of the target over-
produced protein which are called inclusion bodies (IBs). The seed of IB formation is the presence of unproperly 
folded protein which is induced by several factors such as uncontrolled/unfavored growth pH and/or tempera-
ture, oxidative stresses, high rate of heterologous proteins expression (using strong expression vectors or high 
inducer concentrations) which exceeds the protein folding. Additionally, the failure of the cell to post-translation-
ally modify the protein or to form the inter- and intra-subunit disulphide bonds are reasons for IB  formation1–6.
IBs are currently defined as an amorphous mixture of amyloid-like cross molecular beta sheets and native 
(like) folded protein structures that are substantially active and could be further used as such without the need 
to re-fold7–9. They, additionally, often contain the aggregated protein in high concentration with relatively little 
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contamination by other intracellular proteins. For this reason, intentional aggregation of the target protein and 
purification of the resulting IB is a widely used strategy for product concentration and crude purification in the 
pharmaceutical industry. Nonetheless, laborious downstream purification, solubilization and refolding steps are 
typically required to obtain the target protein in the correct (active) folding  state2,5,10.
Catalytically active inclusion bodies (CatIBs) offer a valuable alternative as they can be produced in E. coli 
without the need for laborious solubilization. As such, CatIBs can be used as immobilized enzymes, thus increas-
ing the interest in this class of protein aggregates in recent  years1,2,11. The application of CatIBs offers several 
advantages compared to soluble or synthetically immobilized enzymes. These include compatibility with aque-
ous and non-aqueous media, straightforward and cheap purification, reusability and no loss of activity due to 
 immobilization1.
CatIBs are usually engineered by the addition of small peptide tags or aggregation-inducing protein domains 
to a protein of interest. These folding active centers guide the protein to accumulate in inclusion bodies. While 
most publications so far describe such engineered protein variants forming  CatIBs12–16, only few examples have 
been reported of naturally occurring proteins developing CatIBs during overexpression in E. coli17–20.
Herein, we describe the isolation of in-vivo formed CatIBs and in-vitro formed heat-induced aggregates (HIA) 
of Thermococcus kodakarensis adenosine 5′-monophosphate phosphorylase (TkAMPpase). This enzyme was 
first described in 2007 as a biocatalyst involved in a previously undescribed metabolic pathway in  archaea21–23. 
This pathway is involved in supplying the ribose moiety of 5′-mononucleotides (NMP) to the central carbon 
metabolic pathway(s)21. TkAMPpase phosphorolytically cleaves the N-glycosidic bond of NMP in the presence 
of inorganic phosphate yielding the corresponding nucleobase and ribose-1,5-bisphosphate (R15P; Fig. 1)21–23. 
The enzyme has previously been misannotated as a thymidine phosphorylase until Sato et al.21 recognized its 
function in the AMP metabolic pathway in archaea. Although TkAMPpase’s primary structure is closely related 
to thymidine phosphorylases, it’s quaternary structure was reported to form unusual multimers (> 40-mers)23. 
Previous functional studies showed that the enzyme is highly active at 85 °C and could withstand high tem-
peratures (60–85 °C) for at least 24  h22–24. Aono et al.22 additionally showed that the enzyme accepts all natural 
NMPs and their corresponding 2′-deoxy-NMP (dNMP) with preference for cytidine 5′-monophosphate (CMP).
While we were studying this enzyme in more detail, we discovered that it is prone to aggregation both dur-
ing expression and after exposure to heat in cell crude extract which led us to develop a purification method to 
obtain the insoluble protein as CatIBs. Interestingly, insoluble preparations of TkAMPpase retained high activity 
with all natural 5′-mononucleotides, opening new avenues for the application of this enzyme as a heterogenous 
biocatalyst.
Materials and methods
General information. All chemicals were of analytical grade or higher and purchased, if not stated oth-
erwise, from Sigma-Aldrich (Steinheim, Germany), Carl Roth (Karlsruhe, Germany), TCI Deutschland (Esch-
born, Germany), NMPs were purchased from Carbosynth (Berkshire, UK) or VWR (Darmstadt, Germany). All 
experiments were repeated for at least 3 times unless specified otherwise.
Cloning and expression of TkAMPpase. The Thermococcus kodakarensis gene sequence obtained 
from the national center for biotechnology information (NCBI) database coding AMPpase protein with acces-
sion number WP_011249307.1 was codon-optimized for expression in E. coli and obtained by gene synthesis 
(GeneArt, Regensburg, Germany). The TkAMPpase gene was then cloned via NdeI/HindIII digestion (Fast-
Digest restriction endonucleases, Fermentas, Vilnius, Lithuania) and ligation (T4 DNA Ligase, Roche) into an 
expression vector (pKS-2) modified from pCTUT7 as described  previously25,26.
The N-terminally  His6-tagged TkAMPpase was expressed in E. coli BL21 in shake flask using 50 mL of 
EnPresso B medium (Enpresso, Berlin, Germany) at 30 °C. As recommended by the manufacturer, after overnight 
Figure 1.  The reaction catalyzed by adenosine 5′-monophosphate phosphorylases (AMPpases). The 
N-glycosidic bond of adenosine 5′-monophosphate (AMP) is cleaved in the presence of inorganic phosphate 
yielding adenine and ribose-1,5-bisphosphate (R15P).
3
Vol.:(0123456789)
Scientific Reports |        (2021) 11:16880  | https://doi.org/10.1038/s41598-021-96073-5
www.nature.com/scientificreports/
incubation of the main culture, expression was induced using IPTG with a final concentration of 1 mM. Each 
50 mL culture yielded 1.8–2.2 g cell pellet. The harvest  OD600 was on an average equal to 43.
An  OD600 = 5 cell pellet sample (25 mg wet weight) was used to test the protein expression using BugBuster 
Protein Extraction Reagent (Merck, Darmstadt, Germany). For cell lysis, the cell pellet was incubated for 30 min 
with 300 μL of BugBuster reagent complemented with lysozyme (final conc. of 50 µg  mL−1), DNase (final conc. 
of 1 µg  mL−1) and  MgCl2 (final conc. of 1 mM). The cell lysate was centrifuged (4 °C, 16,000g for 15 min) to 
separate the soluble (S) and insoluble (IS) protein fractions. 5 µL of the protein fractions were analyzed using 12% 
SDS–polyacrylamide gels according to standard  protocols27 and a protein marker ranging from 10 to 200 kDa 
(New England BioLabs, MA, USA). The percentage of soluble and insoluble fractions was quantified from the 
SDS-polyacrylamide gels by densitometric analysis (ImageJ software (National Institute of Health, USA, http:// 
www. imagej. nih. gov/ ij))28.
To purify TkAMPpase three different methods were applied which are summarized in Supp. Table 1. To obtain 
heat induced aggregates and purified soluble protein the cells were disrupted by French Press and the soluble 
fraction was either heat-treated or transferred to Ni-NTA affinity chromatography. To avoid the disruption of 
the active IBs and an associated inactivation French Press cell disruption was not used for CatIB preparation 
and therefore cell disruption was performed by enzymatic lysis and sonification.
Preparation of TkAMPpase as soluble protein in crude extract. For cell disruption, each 1 g of cell 
pellet (wet weight) was resuspended in 5 mL 0.1 M Tris–HCl buffer containing 1 mM EDTA (pH 7). In each 
experiment about 4 g cell pellet (wet weight) was used. Cells were mechanically lysed by French Press to obtain 
soluble TkAMPpase. The French press was used for five consecutive cycles at 900–1000 bar. After each cycle, a 
sample of 1 mL was taken for further analysis. Following cell disruption, the suspension was supplemented with 
a solution of 1.5 M NaCl, 60 mM EDTA, 6% Triton-X100 (pH 7) and 0.1 mM PMSF (half of the remaining vol-
ume each) and incubated for 30 min on ice. Insoluble protein was separated from the soluble one by centrifuga-
tion at 4 °C, 8000g for 10 min (Supp. Fig. 1). 5 µL of both soluble and insoluble protein fractions were analyzed by 
SDS-PAGE. The insoluble fraction was treated with standard SDS loading buffer containing 80 mM urea accord-
ing to the standard  protocols27. The soluble protein fraction obtained after the fifth French press cycle was stored 
at 4 °C for until further use. French Press cell disruption experiment were repeated four independent times.
Purification of soluble TkAMPpase using affinity chromatography. Each 1  g of cell pellet was 
resuspended in 5 mL lysis buffer (50 mM sodium phosphate, 300 mM NaCl, 10 mM imidazole, pH 7) com-
plemented with lysozyme (final conc. of 50 µg  mL−1), DNase (final conc. of 1 µg  mL−1) and  MgCl2 (final conc. 
of 1 mM). The cell suspension was incubated at room temperature (25 °C) for 30 min. Afterwards, cells were 
mechanically lysed by French Press at 900–1000 bar for five consecutive cycles. The lysed cells were centrifuged 
at 4 °C, 8000g for 10 min to separate the soluble and the insoluble fraction. The soluble fraction was loaded 
to a 5 mL Ni-NTA column (Jena biosciences, Jena, Germany). The flowthrough was collected and loaded to a 
second 5 mL Ni-NTA column to maximize the amount of soluble protein obtained. The columns were washed 
three times using washing buffer (50 mM sodium phosphate, 300 mM NaCl, 20 mM imidazole, pH 7). Finally, 
the protein was eluted using elution buffer (50 mM sodium phosphate, 300 mM NaCl, 250 mM imidazole, pH 
7) in five fractions, 2.5 mL each. 5 μL of each fraction of the purification process was analyzed on 12% SDS-
polyacrylamide gels. The insoluble fraction was treated with standard SDS loading buffer containing 80 mM urea 
according to the standard  protocols27.
Purification of CatIBs. For the isolation of CatIBs from E. coli cultures, 1 g of cell pellet was resuspended 
in 5 mL of 0.1 M Tris–HCl buffer (pH 7) containing 1 mM EDTA and 1.5 mg  mL−1 lysozyme. The cell suspen-
sion was then incubated for 30 min at room temperature (approximately 25 °C) followed by mechanical lysis on 
ice using sonification for 5 min with 30% power input and 30 s on/off intervals. The mixture was then treated 
with DNase (final concentration of 50 µg) in the presence of 3 mM  MgCl2 and 0.1 mM PMSF. After incubation 
at 37 °C for 30 min, a solution of 1.5 M NaCl, 60 mM EDTA and 6% Triton-X100 (pH 7) was added (half of the 
current volume). The cell suspension was then incubated for 30 min on ice. To evaluate the cell lysis efficiency, 
a 100 µL sample was taken, the soluble (S) and insoluble proteins (IS) were separated by centrifugation (4 °C, 
16,000g for 15 min). For the SDS-PAGE analysis 2 µL of 1:10 dilution was loaded on the gel.
The IBs were collected by centrifugation of the cell suspension (4 °C, 8000g for 10 min), followed by three 
successive washing steps each with 40 mL of 0.1 M Tris–HCl containing 20 mM EDTA (pH 7). 500 µL sample 
was taken after each washing step and 10 µL from each (W1, W2 and W3) was loaded on the SDS polyacrylamide 
gel. The isolated IBs were stored at 4 °C until further use. For SDS-PAGE analysis, soluble protein fraction and 
wash samples were treated with SDS loading buffer, while insoluble protein fraction and IB were treated with 
SDS loading buffer containing 80 mM urea according to standard  protocols27. For the purpose of detection, 2 µL 
of IB in a 1:16 dilution was loaded on the SDS-PAGE. For activity assays 0.2 g of isolated IBs were resuspended 
in 500 µL MOPS buffer (50 mM, pH 7.5).
Aggregation of TkAMPpase from the crude extract by heat. 1.5 mL of the soluble TkAMPpase 
obtained after the fifth French press cycle was incubated at different temperatures (room temperature (approxi-
mately 25 °C), 40, 50, 60, 70, 80 and 90 °C) to induce protein aggregation (Supp. Fig. 1). 200 µL samples were 
taken at 15, 30, 45 and 60 min and stored on ice. The heat-induced aggregates (HIAs) were collected by centrifu-
gation (4 °C, 16,000g for 10 min). The obtained aggregates were resuspended in 200 µL solution of 1.5 M NaCl, 
60 mM EDTA, 6% Triton-X100 (pH 7). For SDS-PAGE analysis, 2 µL of 1:10 dilutions of soluble and the HIAs 
were treated with standard SDS loading buffer and SDS loading buffer containing 80 mM urea, respectively, 
4
Vol:.(1234567890)
Scientific Reports |        (2021) 11:16880  | https://doi.org/10.1038/s41598-021-96073-5
www.nature.com/scientificreports/
according to standard  protocols27. Using densitometric analysis (ImageJ software (National Institute of Health, 
USA, http:// www. imagej. nih. gov/ ij))28 the relative amount of HIAs was calculated as a percentage of the total 
TkAMPpase protein (soluble and insoluble) per time point according to the formula below
Standard deviations were calculated from three independent experiments. For analysis of the specific activity 
with 5′-mononucleotides, 0.2 g of HIAs were resuspended in 500 µL MOPS buffer (50 mM, pH 7.5).
Analysis of the thermostability of His‑tag purified TkAMPpase. 1.5 mL of 1 mg  mL−1 of the his-
tagged purified TkAMPpase was incubated at 60 or 80 °C for 1 h or 24 h. Samples were cooled on ice for 30 min 
and centrifuged at maximum speed for 30 min. 500 µL samples were taken, 10 µL were loaded on 12% SDS-
polyacrylamide gels and TKAMPpase was quantified with densitometric analysis of the polyacrylamide gels 
using ImageJ software (National Institute of Health, USA, http:// www. imagej. nih. gov/ ij)28. The percentage of the 
formed aggregation is calculated relative to the density of the sample not treated with heat (which is set to 100%).
Quantification of the TkAMPpase CatIB and HIA. BSA was used as a standard to determine TkAMP-
pase concentrations from different preparations (HIAs and IBs) using SDS-PAGE. Three different concentrations 
of BSA (0.5, 0.25 and 0.1 mg  mL−1) were loaded on 12% SDS–polyacrylamide gels in duplicates. The concentra-
tions were chosen to be in the linear detection range. The densities of the bands were analyzed using ImageJ 
software (National Institute of Health, USA, http:// www. imagej. nih. gov/ ij)28 and standard curves were generated 
(Supp. Fig. 2). Serial dilution of the HIAs and CatIBs of TkAMPpase were loaded on SDS–polyacrylamide gels 
and the band densities were quantified using the BSA standard curve as a reference (Supp. Fig. 3 and 4).
Protein quantification by a modified Bradford assay. For the quantification of the total protein 
and the His-tag purified protein, Roti-Nanoquant reagent (Carl Roth, Karlsruhe, Germany) was used. BSA was 
used as a standard with 9 different concentrations ranging between (0–100 µg  mL−1). All samples were properly 
diluted to fit within the range of the standards. The assay was performed in 96 deep-well plate and the absorb-
ance was measured at 450 and 590 nm as recommended by the manufacturer. All the measurements were per-
formed at least in triplicates.
Enzyme activity assay. The specific activity of the His-tag purified, HIAs and CatIBs of TkAMPpase were 
tested with natural NMPs. A proper dilution was used in which the enzyme  OD260 did not exceed 0.1. Reactions 
were performed with 2 mM nucleotide and 50 mM phosphate in 50 mM MOPS buffer (pH 7) in the presence 
of 50–100 µg  mL−1 enzyme at 80 °C. Regular samples were taken to monitor the initial rates of the reactions 
(< 12% product formation). The minimum reaction time was 2.5  min for His-tag purified TkAMPpase and 
the maximum was 40 min for HIAs obtained at 90 °C. Samples were stopped and quenched by adding 40 µL 
of reaction mixture to 460 µL of 0.5 M NaOH (CMP-containing reactions) or 0.1 M NaOH (AMP-, GMP- and 
UMP-containing reactions). The nucleobase/nucleotide ratio in each sample was obtained via deconvolution of 
the experimental UV absorption spectra using suitable reference spectra obtained under the same conditions as 
described  previously29,30. The specific activities were calculated in units (U) per mg enzyme, where one U is the 
conversion of 1 µmol substrate per minute under the conditions stated above.
Results and discussion
Heterologous expression of TkAMPpase. To study TkAMPpase in more detail, we expressed TkAMP-
pase using an IPTG-inducible expression vector and an EnPresso B medium which mimics the glucose limited 
fed-batch cultivation process in shake flasks. This ensures a controlled glucose release, bacterial growth and 
subsequently increases the efficiency of target gene expression. 50 mL culture yields around 1.9–2.2 g of cell 
pellet (wet weight). The recombinant TkAMPpase (54 kDa) was expressed mainly in the insoluble fraction as 
detected in samples  (OD600 = 5) taken after expression (Fig. 2a, Supp. Fig. 11). On average, about 80% of the 
totally expressed TkAMPpase was found in the insoluble fraction as calculated using densitometric analysis. We 
attributed this to TkAMPpase forming unusually large multimers (> 40-mers)23. This multimeric structure was 
described to be linked together by 10 amino acid residues in the C-terminal domain. Additionally, the protein 
N-terminus (84 amino acid) contributes to the multimer formation. Although the relation between the protein 
oligomerization state and its solubility is not well reported, there are few reports suggesting that multimeric 
proteins such as l-asparaginase and beta-galactosidase (both tetramer) tend to aggregate during heterologous 
 expression8,20. In previous reports, TkAMPpase was described to be expressed in the soluble protein  fraction22,23, 
however, the insoluble fractions were not analyzed in these reports (personal communication). Accordingly, 
the multimeric structure of TkAMPpase might explain its aggregation during expression. Nonetheless, it is also 
plausible that expression conditions such as expression vector, strain, medium and others may have an impact 
on the solubility of the expressed  protein5,31. The authors of the previous work have used a pET21a vector, a BL21 
(DE3) expression strain and LB medium at 37 °C22,23, which might have had a positive impact on the soluble 
expression of TkAMPpase.
Optimized preparation of soluble TkAMPpase. Since TkAMPpase was obtained primarily as insolu-
ble protein, we developed a high-pressure cell disruption protocol using a French press. Pressure of up to 2 kbar 
has previously been reported to disrupt the oligomerization of some proteins such as glyceraldehyde-3-phos-
Percentage of HIA =
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phate dehydrogenase, lactate dehydrogenase, malate dehydrogenase or tryptophan synthase, which led us to 
hypothesize that a similar strategy might be employed to solubilize TkAMPpase32,33. Our results showed that 
after five consecutive cell disruption cycles at 900 bar, the amount of the recombinant TkAMPpase in the soluble 
fraction increased to 30% after the fifth French Press cycle with a stepwise increase after each cycle. The same 
pattern was observed upon using different volumes of lysis buffer (5, 10, 20 mL; Fig. 2b, Supp. Fig. 5). One gram 
of wet cell pellet yielded around 120 mg total protein as determined by the modified Bradford assay.
Figure 2.  Solubilization and formation of heat-induced aggregates (HIAs) of TkAMPpase. (a) SDS-PAGE 
analysis of 4 µL both soluble (S) and insoluble (IS) protein fractions of  OD600 = 5 samples after the expression of 
TkAMPpase in E. coli using Enpresso B medium. The TkAMPpase (54 kDa) is mainly detected in the insoluble 
fraction (IS) after cell disruption using BugBuster Protein Extraction Reagent. M: protein marker. (b) 5 µL of 
the protein fractions obtained from French Press cell disruption at 900 bar analyzed by SDS-PAGE. (c) The fifth 
French Press fraction of the soluble protein was further purified by heat treatment at 80 °C for 30 min which 
resulted in a significant re-aggregation of the protein and its accumulation in the insoluble fraction. The marker 
(M) lane and the sample lanes are rearranged from the same gel. The complete SDS-PAGE from (a), (b) and (c) 
are shown in the supplementary material. (d) The induction of aggregation by heat at different temperatures 
within 1 h. Room temperature (approximately 25 °C) was used as a negative control to examine spontaneous 
aggregation. Chart is generated based on densitometric analysis of SDS–polyacrylamide gels using ImageJ 
software. (e) The specific activity of all aggregates was determined with 2 mM CMP and 50 mM phosphate in 
50 mM MOPS buffer (pH 7.5) at 80 °C.
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Formation of heat‑induced aggregates (HIAs). TkAMPpase is derived from a thermostable archaeon 
with an optimum growth temperature of 85 °C34. Therefore, heat treatment is a valuable tool to purify TkAMP-
pase. To explore this strategy, we subjected crude preparations of the soluble protein (obtained after the fifth 
French press cycle) to 80 °C for 30 min. Thermal treatment of the soluble crude extract containing TkAMPpase 
led to almost complete precipitation of TkAMPpase (Fig. 2c). To study this effect in more detail, the impact of 
temperature on the enzyme’s solubility and the formation of aggregates was evaluated. Therefore, the soluble 
crude extract containing TkAMPpase was incubated at six temperatures (from 40 to 90 °C in 10 °C increments) 
and aggregate formation was assessed every 15 min for 1 h. Room temperature (approximately 25 °C) was used 
to evaluate spontaneous aggregation. The relative amount of the formed aggregates was calculated as a percent-
age of the total TkAMPpase amount (soluble and insoluble) of the protein (Fig. 2d, Supp. Fig. 6). At the lower 
tested temperatures (40 °C, 50 °C and 60 °C), an increase of the percentage of aggregates over time was observed. 
While a steady increase corresponding to an aggregation rate of 0.84  h−1 was monitored at 40 °C (Supp. Fig. 7), 
the aggregation at higher temperatures quickly reached a plateau of around 75% (50 °C) and 80% (60 °C). At 
even higher temperatures (70–90 °C), 80% aggregation was already detectable after 15 min with no significant 
change within the remaining hour (Fig. 2d). The aggregation observed at 25 °C was negligible (< 5%) and did not 
increase over time. We attribute these observations to the formation of thermally stable multimers of TkAMP-
pase which aggregate as insoluble proteins. Our results reveal that this aggregation happens at temperatures as 
low as 40 °C with a highly temperature-dependent rate.
Thermal stability analysis of the purified TkAMPpase. In previous reports, a high thermal stability 
of purified TkAMPpase was  described23. Therefore, we evaluated the thermal stability of the Ni-NTA purified 
protein. Thus, using the described cell disruption methods, the N-terminal His-tagged TkAMPpase was puri-
fied using a Ni-NTA agarose resin. As only few amounts of the protein bound to the column despite the high 
column capacity (250 mg of protein) another column was loaded with the flow-through of the first purification 
step. Nonetheless, TkAMPpase remained mostly in the flowthrough (Fig. 3a,b). 1 g of cell pellet yielded around 
6.9 mg of purified TkAMPpase as determined by modified Bradford assay.
The purified TkAMPpase was stable at 60 °C and at 80 °C for 1 h as determined by SDS-PAGE (Fig. 3c) and 
densitometric analysis. After 24 h, however, about 10% and 30% of the protein was precipitated at 60 °C and 
80 °C, respectively, as determined by the densitometric analysis of the SDS-polyacrylamide gels which is much 
less than the aggregation observed from the crude extract (80% at 60 °C and 80 °C after 1 h, Fig. 2d). The higher 
rate of TkAMPpase precipitation from the crude extract could be attributed to the crowded environment of the 
crude extract together with the presence/abundance of partially unfolded proteins (from E. coli or from the target 
protein) as a result of heat treatment. Such an environment facilitates the initiation and progression of protein 
 assembly35,36. Furthermore, protein concentrations are much less in purified protein preparations compared to 
crude extracts, which might also influence protein aggregation.
Specific activity of the HIA using CMP as a substrate. As it has been reported that TkAMPpase mul-
timers show activity towards a variety of 5′-mononucleotides23, we questioned if the formed HIAs retained phos-
phorolytic activity. Based on previously reported experimental  data22, we used the phosphorolysis of CMP as a 
model reaction to determine the specific activity of the HIAs at 80 °C. These experiments revealed that all HIAs 
have catalytic activity with values of 0.08–0.2 U  mg−1 (Fig. 2e). The HIAs obtained through aggregation between 
40 and 60 °C showed no significant differences in their specific activities. In contrast, the aggregates formed at 
temperatures between 70 and 90 °C displayed a gradual decrease in their specific activity with the lowest activity 
observed after aggregation at 90 °C (Fig. 2e, Supp. Fig. 8). These data suggest that with increasing temperature 
Figure 3.  Ni-NTA purification of His-tagged TKAMPpase and its thermal stability. (a,b) 12% SDS-
polyacrylamide gels showing the samples taken during the purification of TKAMPpase. Loaded sample (LS), 
flowthrough (FT), wash fractions (W1, W2, W3) and elution fractions (E1–E6). The FT from column 1 was 
loaded consecutively to column 2. (c) Heat treatment of the purified TkAMPpase by incubation at 60 °C and 
80 °C for 1 h and 24 h. A sample was taken before incubation (0 h).
7
Vol.:(0123456789)
Scientific Reports |        (2021) 11:16880  | https://doi.org/10.1038/s41598-021-96073-5
www.nature.com/scientificreports/
more TkAMPpase is denatured. However, full denaturation of TkAMPpase was not observed under the applied 
conditions and all HIA preparations retained activity.
Purification of CatIBs. Since TkAMPpase is mainly expressed in the insoluble fraction and even aggre-
gated protein showed activity in a model reaction, IB isolation seemed like an attractive alternative for protein 
purification. Therefore, we attempted to isolate active IBs of TkAMPpase after expression in E. coli. To avoid the 
disruption of the in-vivo formed IB, sonication was used as a gentler cell disruption method compared to the 
French Press treatment applied before. This method yielded intact in-vivo formed IBs which were successfully 
purified directly from the insoluble protein fraction (Fig. 4a,b). 1 g of wet cell pellet yielded approximately 0.5 g 
of IBs (wet weight) which contained approximately 38 mg TkAMPpase per gram cell pellet (wet weight; Supp. 
Fig. 4), which is about 10 times the amounts obtained from the Ni-NTA purification.
Specific activity of CatIBs of TkAMPpase in comparison to HIAs and purified protein. Initially, 
the activity of the TkAMPpase IB was studied using CMP as substrate. A substrate conversion of 26% was 
recorded. To prove that the observed activity is not based on dissolved TkAMPpase from the IB, preparations 
were incubated at 60 °C or 80 °C for 2.5 h. IB were then collected by centrifugation. To fully remove traces of 
IBs, the soluble fraction was additionally filtered through a 0.45 µm filter. AMPpase activity of the soluble frac-
tion and the collected IB was analyzed at 80 °C. Almost no activity was detected for the supernatant of the 80 °C 
incubated preparation (0.1%), whereas a negligible activity (1.9%) was observed for the ones incubated at 60 °C. 
In contrast, the collected IB from 80 °C and 60 °C showed substrate conversions of 13% and 18%, respectively 
(Supp. Fig. 9).
Next, we compared the activity of the purified IBs of TkAMPpase to the activity of the His-tag purified 
enzyme and HIAs formed at 60 °C after 1 h (Fig. 4c). AMP, GMP, CMP and UMP were applied as substrates 
in the presence of phosphate at 80 °C. The heat induced aggregates showed the lowest activity among the three 
different TkAMPpase preparations. The isolated IBs showed two- to sixfold higher specific activities towards 
all substrates compared to the HIAs except for GMP (Fig. 4c). However, our CatIBs displayed lower specific 
activities (2.5–3 folds) compared to the His-tag purified TkAMPpase for all tested substrates except for CMP. 
CatIBs specific activity for CMP was 1.5 and 6 folds higher than those of the His-tag purified enzyme and the 
HIA preparation, respectively. The specific activities of the three preparations were lower than those previously 
 reported22, however reaction set up was different. We used a high ratio of phosphate to substrate (25:1), whereas 
previous reports used an equimolar phosphate and substrate concentration.
Figure 4.  Expression and purification of CatIBs. (a) The utilized protocol for IB isolation. (b) 12% SDS-
polyacrylamide gels showing the different steps of IB isolation. After cell disruption using sonification 
TkAMPpase was expressed mainly in the insoluble fraction (IS) (2 µL of 1:10 dilution was used on the gel). 
Washing steps with Tris–HCl buffer were applied to decrease protein background (10 µL from each (W1, W2 
and W3) was loaded on the SDS PAGE). The final IB preparation showed only minor impurities (IB) (2 µL of 
IB in a 1:16 dilution was loaded on the SDS-PAGE). (c) Specific activity of the CatIBs compared to the HIAs 
obtained from 60 °C heat treatment after 60 min was determined. The used reaction conditions were 2 mM 
substrate (NMP) and 50 mM potassium phosphate in MOPS buffer (pH 7) at 80 °C. Regular samples were 
taken at different time points over a period of 15 min. Standard deviation is derived from three experiments. M 
protein ladder, IS insoluble protein fraction, S soluble protein fraction. Cell disruption method: sonification.
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Interestingly, a comparison between the activities of different enzyme preparations (HIA, CatIB and soluble 
enzyme) revealed a difference in the substrate preferences. The CatIBs showed the highest activity with CMP, 
while GMP is the preferred substrate for HIAs and the soluble TkAMPpase (Supp. Fig. 10). Altered substrate 
preferences is additionally observed as compared to published activity of the soluble enzyme where AMP was the 
second most preferred  substate22, while, our three different preparation have the least activity towards AMP. There 
are increasing evidences that aggregates formed under different conditions (including different temperatures) 
display morphological  differences37–39, with differences in secondary and tertiary structure additionally altering 
their  function38. Since rather little is known about AMPpases, this class of enzymes requires further studies to 
develop a better understanding of their structure function relationships and aggregation behavior.
Conclusion
TkAMPpase belongs to the small group of enzymes that naturally forms CatIBs without an artificial tag during 
its heterologous expression in E. coli. Whereas high pressures enabled obtaining the enzyme in the soluble frac-
tion, heat treatment of the crude soluble extract at various temperatures induces the re-formation of insoluble 
aggregates. The CatIBs were highly active and were obtained in high quantities as compared to the in-vitro heat 
induced aggregates and to the His-tag purified enzyme. Although further work is necessary to gain a better 
understanding of the substrate spectrum of TkAMPpase as well as the reasons for the observed aggregation, 
the results presented in this study encourage exploration of this enzyme as a self-immobilizing biocatalyst for 
applications in heterogenous reaction systems.
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